Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 117,453 | 129,743 | 69,314 | 0 | N/A |
| TOTAL | $119,595 | $132,365 | $69,479 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,612 | 4,593 | 4,430 | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 3,412 | 0 | 0 |
| TOTAL | $4,612 | $4,593 | $7,842 | $N/A | $N/A |
| Total Assets | $124,207 | $136,958 | $77,321 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 3,884 | 0 | N/A |
| Accounts payable and accrued liabilities | 1,206 | 1,601 | 2,550 | 0 | 0 |
| Accrued Expenses | 1,434 | 3,649 | 2,921 | 0 | N/A |
| TOTAL | $2,640 | $5,250 | $9,355 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,116 | 25,558 | 6,091 | 5,598 | 0 |
| TOTAL | $N/A | $N/A | $606 | $N/A | $N/A |
| Total Liabilities | $2,640 | $5,250 | $9,961 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,160 | 49,002 | 49,005 | N/A | N/A |
| Common Shares | 5 | 5 | 1,412 | 0 | N/A |
| Retained earnings | -8,331 | -3,142 | -125,086 | 0 | N/A |
| Other shareholders' equity | 74,156 | 80,342 | 191,034 | 0 | 0 |
| TOTAL | $121,567 | $131,708 | $67,360 | $0 | $N/A |
| Total Liabilities And Equity | $124,207 | $136,958 | $77,321 | $0 | $0 |